New Study (released in 2015) Supports Experience that T4 Monotherapy Does Not Work
Here is a new piece of research that further supports our experience that T4 monotherapy using Levothyroxine is problematic and cannot re-create our previously healthy levels of FT4 and FT3:
The study in rats at present actually found that T4 monotherapy resulted in lower than required FT3 levels. This was corrected with continuous release of both T4 and T3 medication in an appropriate ratio.
I found this to be encouraging. Perhaps the science will eventually result in dismissal of the T4/Levothyroxine dogma we are faced with today.